Adamis Pharmaceuticals reported $1.51M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Adamis Pharmaceuticals ADMP:US USD 1.51M 1.47M
Adma Biologics ADMA:US USD 41.09M 7.18M
Cara Therapeutics CARA:US USD 10.81M 12.19M
Glaxosmithkline GSK:US GBP 7.83B 900M
GlaxoSmithKline GSK:LN GBP 782.9B 90B
Merk MRK:US USD 14.96B 366M
Pfizer PFE:US USD 22.64B 5.1B